Interpretation of Hemoglobin A1c Levels

Understanding HbA1c Values

HbA1c reflects time-averaged blood glucose during the previous 2-3 months and is used as the gold standard for long-term assessment of glycemic control 1
According to the American Diabetes Association (ADA) guidelines, HbA1c values correlate with mean glucose levels as follows:
- HbA1c 5% ≈ 97 mg/dL (76-120 mg/dL) 2
- HbA1c 6% ≈ 126 mg/dL (100-152 mg/dL) 3
By extrapolation, an HbA1c of 4.7% would correspond to an estimated average glucose of approximately 88 mg/dL, which is within the normal non-diabetic range 3

The diagnostic criteria established by the American Diabetes Association (ADA) define:
- Diabetes: HbA1c ≥ 6.5% (48 mmol/mol) 2
- Prediabetes: HbA1c 5.7-6.4% (39-47 mmol/mol) 2
- Normal: HbA1c < 5.7% (< 39 mmol/mol) 2, 4, 5
An HbA1c of 4.7% falls well within the normal range, indicating no evidence of diabetes or prediabetes 5

This HbA1c value suggests excellent glycemic control if the patient is already diagnosed with diabetes and on treatment 6, 7
In a non-diabetic individual, this value represents normal physiological glucose regulation 5
The American College of Physicians (ACP) recommends that HbA1c targets should be individualized, with a general target between 7-8% for most patients with type 2 diabetes 6, 7
An HbA1c of 4.7% may potentially indicate:
- Normal glucose metabolism in a healthy individual 5
- Excellent glycemic control in a treated diabetic patient 3
- Possible falsely low reading in certain clinical conditions 8

Falsely low HbA1c values can occur in conditions affecting red blood cell turnover, including:
- Recent blood transfusion 4
- Hemoglobinopathies (e.g., sickle cell trait) 8
- Pregnancy (second and third trimesters) 4
- Erythropoietin therapy 4
- End-stage kidney disease 8
Certain hemoglobin variants can interfere with HbA1c measurement, potentially causing discrepancies between measured HbA1c and actual glycemic status 2, 5
African American individuals with the common hemoglobin variant HbS may have lower A1C by about 0.3% compared to those without the trait for the same level of mean glycemia 8, 5

For a patient with an HbA1c of 4.7%:
- If not diabetic: Reassure that glycemic status is normal 5
- If diabetic on medication: Evaluate for possible hypoglycemia risk, especially if on insulin or sulfonylureas 3
- Consider checking for conditions that might cause falsely low HbA1c readings if clinical presentation doesn't match this value 8
Ensure the HbA1c test was performed using a method certified by the National Glycohemoglobin Standardization Program (NGSP) and standardized to the Diabetes Control and Complications Trial (DCCT) assay 2, 1
If there is marked discrepancy between measured HbA1c and plasma glucose levels, consider using alternative methods for assessing glycemic status 8, 5

The American Diabetes Association defines HbA1c categories as follows: Normal < 5.7 %, Prediabetes 5.7–6.4 %, and Diabetes ≥ 6.5 %【9】【10】.

Hemoglobinopathies such as sickle‑cell trait reduce HbA1c by approximately 0.3 %【9】.
Pregnancy during the second or third trimester is associated with lower HbA1c values【9】.
Recent acute blood loss or transfusion can produce spuriously low HbA1c【9】.
Hemolytic disorders and erythropoietin therapy also tend to lower measured HbA1c【9】.

Iron‑deficiency anemia is the most common cause of falsely elevated HbA1c because prolonged red‑cell lifespan increases glycation【9】.

Fructosamine and glycated albumin reflect average glucose over the preceding 1–2 weeks and are not influenced by red‑cell turnover, making them useful when HbA1c reliability is in doubt【11】.

A 1 % increase in HbA1c corresponds to an approximate 35 mg/dL rise in mean plasma glucose, establishing a linear relationship useful for estimating average glucose from HbA1c【12】.

A protective lipid profile (low triglycerides, high HDL) is linked to reduced cardiovascular risk, as highlighted in ADA guidance【10】.